This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB07048/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07048/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07048/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07048/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07048
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07048 n10:DB07048
dcterms:title
N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide
adms:identifier
n8:23653514 n9:99443519 n12:DB07048 n13:3CC
n3:IUPAC-Name
n4:271B4492-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4498-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4497-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4494-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4495-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4496-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4490-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B448E-363D-11E5-9242-09173F13E4C5 n4:271B4491-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B448F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B449E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B449F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4499-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B449A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B449C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B449B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B449D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B44A4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B44A6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B44A7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B44A3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B44A2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B44A5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4493-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B44A0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B44A1-363D-11E5-9242-09173F13E4C5